September 5, 2012 / 8:33 PM / 5 years ago

Nordion posts 3rd-quarter profit

Sept 5 (Reuters) - Canadian medical isotope supplier Nordion Inc posted a quarterly profit, helped by growth in its Targeted Therapies segment.

Net earnings for the third quarter were $12.3 million, or 20 cents per share, compared with a loss of $4.1 million, or 6 cents per share, a year earlier.

Revenue rose marginally to $67.1 million. Targeted Therapies revenue increased 15 percent to $15.3 million.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below